Goldberg MS - Search Results

1

DNA Damage and Repair Biomarkers of Immunotherapy Response.

Mouw KW, Goldberg MS, Konstantinopoulos PA, D'Andrea AD. Mouw KW, et al. Among authors: goldberg ms. Cancer Discov. 2017 Jul;7(7):675-693. doi: 10.1158/2159-8290.CD-17-0226. Epub 2017 Jun 19. Cancer Discov. 2017. PMID: 28630051 Free PMC article. Review.

2

Improving cancer immunotherapy with DNA methyltransferase inhibitors.

Saleh MH, Wang L, Goldberg MS. Saleh MH, et al. Among authors: goldberg ms. Cancer Immunol Immunother. 2016 Jul;65(7):787-96. doi: 10.1007/s00262-015-1776-3. Epub 2015 Dec 8. Cancer Immunol Immunother. 2016. PMID: 26646852 Free PMC article. Review.

3

Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model.

Wang L, Amoozgar Z, Huang J, Saleh MH, Xing D, Orsulic S, Goldberg MS. Wang L, et al. Among authors: goldberg ms. Cancer Immunol Res. 2015 Sep;3(9):1030-41. doi: 10.1158/2326-6066.CIR-15-0073. Epub 2015 Jun 8. Cancer Immunol Res. 2015. PMID: 26056145

4

Targeting myeloid cells using nanoparticles to improve cancer immunotherapy.

Amoozgar Z, Goldberg MS. Amoozgar Z, et al. Among authors: goldberg ms. Adv Drug Deliv Rev. 2015 Aug 30;91:38-51. doi: 10.1016/j.addr.2014.09.007. Epub 2014 Oct 2. Adv Drug Deliv Rev. 2015. PMID: 25280471 Review.

5

Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer.

Hartl CA, Bertschi A, Puerto RB, Andresen C, Cheney EM, Mittendorf EA, Guerriero JL, Goldberg MS. Hartl CA, et al. Among authors: goldberg ms. J Immunother Cancer. 2019 Jul 30;7(1):199. doi: 10.1186/s40425-019-0654-5. J Immunother Cancer. 2019. PMID: 31362778 Free PMC article.

6

Immunoengineering: how nanotechnology can enhance cancer immunotherapy.

Goldberg MS. Goldberg MS. Cell. 2015 Apr 9;161(2):201-4. doi: 10.1016/j.cell.2015.03.037. Cell. 2015. PMID: 25860604 Free article. Review.

7

The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.

Waks AG, Stover DG, Guerriero JL, Dillon D, Barry WT, Gjini E, Hartl C, Lo W, Savoie J, Brock J, Wesolowski R, Li Z, Damicis A, Philips AV, Wu Y, Yang F, Sullivan A, Danaher P, Brauer HA, Osmani W, Lipschitz M, Hoadley KA, Goldberg M, Perou CM, Rodig S, Winer EP, Krop IE, Mittendorf EA, Tolaney SM. Waks AG, et al. Clin Cancer Res. 2019 Aug 1;25(15):4644-4655. doi: 10.1158/1078-0432.CCR-19-0173. Epub 2019 May 6. Clin Cancer Res. 2019. PMID: 31061067 Free PMC article.

8

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.

Schmid D, Park CG, Hartl CA, Subedi N, Cartwright AN, Puerto RB, Zheng Y, Maiarana J, Freeman GJ, Wucherpfennig KW, Irvine DJ, Goldberg MS. Schmid D, et al. Among authors: goldberg ms. Nat Commun. 2017 Nov 23;8(1):1747. doi: 10.1038/s41467-017-01830-8. Nat Commun. 2017. PMID: 29170511 Free PMC article.

9

Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases.

Park CG, Hartl CA, Schmid D, Carmona EM, Kim HJ, Goldberg MS. Park CG, et al. Among authors: goldberg ms. Sci Transl Med. 2018 Mar 21;10(433):eaar1916. doi: 10.1126/scitranslmed.aar1916. Sci Transl Med. 2018. PMID: 29563317

10

Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer.

Talekar M, Ouyang Q, Goldberg MS, Amiji MM. Talekar M, et al. Among authors: goldberg ms. Mol Cancer Ther. 2015 Jul;14(7):1521-31. doi: 10.1158/1535-7163.MCT-15-0100. Epub 2015 May 11. Mol Cancer Ther. 2015. PMID: 25964202 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters